President Donald Trump recently released an executive order temporarily halting Foreign Corrupt Practices Act investigations and enforcement actions.

The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.

The Foreign Corrupt Practices Act has, in just a couple of decades, become a huge revenue driver for many law firms.

Although President Trump can't overturn the Foreign Corrupt Practices Act, experts say he can change how it is enforced.

An anti-bribery law whose enforcement President Donald Trump suspended has been used by the Justice Department to win ...

The order pauses new FCPA criminal cases, directs review of existing cases, and leaves open several questions, including implications for ...

Paul Weiss attorneys and former top DOJ officials Loretta Lynch, John Carlin & Mark Mendelsohn analyze implications of AG ...

The White House claimed that the law has been a drag on U.S. business competitiveness and drained resources from both ...

The FCPA was passed in 1977 to address widespread foreign bribery by multinationals that were discovered in the wake of the ...

The Foreign Corrupt Practices Act of 1977, or FCPA, prohibits people or companies operating in the U.S. from giving money or ...

President Donald Trump has called for an end to an act that prohibits American businesses from bribing foreign governments to gain business deals abroad. On Monday, Trump issued an executive order for ...

as American officials tell groups they must obey an almost universal stop-work order issued by Secretary of State Marco Rubio after Trump's directive. (KENNY HOLSTON/The New York Times) ...